Author: Kaye

Kaye

Kaye obtained her Masters of Pharmacy degree from the University College London and has spent the better part of her career as a clinical pharmacist in a tertiary care hospital. Her professional interests are centred on HEOR and HTA work, in hopes of ultimately influencing cost-effective decisions for patient care.

Thalidomide (Old Drug for New Indication: Multiple Myeloma)

By KayeAugust 11, 20220

Thalidomide possesses immunomodulatory, anti-inflammatory and antiangiogenic effects. Find out why it is effective against Myeloma cells

Tepotinib (Tepmetko) for METex14-altered NSCLC

By KayeJuly 27, 20220

Tepotinib (Tepmetko) was recently approved for the use of Non-Small Cell Lung Cancer (NSCLC). We break down the results of Phase II VISION trial in this article.

Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)

By KayeJuly 14, 20221

The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis

By KayeJune 30, 20220

Among the many new drug approved for the use of atopic dermatitis or eczema, dupilumab (Dupixent) is one of them. Find out about its evidence here.

Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)

By KayeJune 16, 20220

Biologics For Severe Asthma: A Review of Dupilumab (Dupixent)

By KayeJune 2, 20220

HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

By KayeMay 19, 20220

HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis

By KayeMay 5, 20220

Contrave: A New Treatment Option For Weight Management

By KayeApril 14, 20220

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

By KayeApril 7, 20220

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

5 Strategies for Doctors to Attract More Patients

The Placebo Effect of Vitamins: Belief vs Reality

Does Freezing Bread Really Lower Its Glycaemic Index?

Author: Kaye

Thalidomide (Old Drug for New Indication: Multiple Myeloma)

Tepotinib (Tepmetko) for METex14-altered NSCLC

Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)

The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis

Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)

Biologics For Severe Asthma: A Review of Dupilumab (Dupixent)

HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)

HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis

Contrave: A New Treatment Option For Weight Management

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

5 Strategies for Doctors to Attract More Patients

The Placebo Effect of Vitamins: Belief vs Reality

Does Freezing Bread Really Lower Its Glycaemic Index?

How Telemedicine is Transforming The Way Singaporeans Manage Diabetes

Subscribe to Updates

What's Hot

Author: Kaye

Subscribe to Updates